Gene · 58508
Papers4,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 4,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gallbladder adenocarcinomas undergo subclonal diversification and selection from precancerous lesions to metastatic tumors. | Elife | 2022 | 36476508 | PubTator, text mining | PubMed |
| Somatic Variants in SVIL in Cerebral Aneurysms. | Neurol Genet | 2022 | 36475054 | PubTator, text mining | PubMed |
| Protein profiling by reverse phase protein array (RPPA) in classical hairy cell leukemia (HCL) and HCL-variant. | EJHaem | 2022 | 36467805 | PubTator, text mining | PubMed |
| Dysregulation of FBW7 in malignant lymphoproliferative disorders. | Front Oncol | 2022 | 36457505 | PubTator, text mining | PubMed |
| Double knockout CRISPR screen for cancer resistance to T cell cytotoxicity. | J Hematol Oncol | 2022 | 36456981 | PubTator, text mining | PubMed |
| A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer. | Front Immunol | 2022 | 36451815 | PubTator, text mining | PubMed |
| Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancer. | Nature | 2022 | 36450981 | PubTator, text mining | PubMed |
| Prognostic value of circulating tumour DNA during post-radiotherapy surveillance in locally advanced esophageal squamous cell carcinoma. | Clin Transl Med | 2022 | 36437506 | PubTator, text mining | PubMed |
| Next Generation Sequencing of Reactive Stroma and Residual Breast Cancer Cells in Tumor Bed after Neoadjuvant Chemotherapy. | Cancers (Basel) | 2022 | 36428702 | PubTator, text mining | PubMed |
| Gallbladder Cancer: Current Multimodality Treatment Concepts and Future Directions. | Cancers (Basel) | 2022 | 36428670 | PubTator, text mining | PubMed |
| KMT2C mutation is a diagnostic molecular marker for primary thyroid osteosarcoma: A case report and literature review. | Front Med (Lausanne) | 2022 | 36425109 | PubTator, text mining | PubMed |
| Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility. | Hum Genomics | 2022 | 36424660 | PubTator, text mining | PubMed |
| Recent Updates on Source, Biosynthesis, and Therapeutic Potential of Natural Flavonoid Luteolin: A Review. | Metabolites | 2022 | 36422285 | PubTator, text mining | PubMed |
| Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies. | Nat Commun | 2022 | 36418296 | PubTator, text mining | PubMed |
| Molecular Typing and Clinical Characteristics of Synchronous Multiple Primary Colorectal Cancer. | JAMA Netw Open | 2022 | 36416825 | PubTator, text mining | PubMed |
| Characterization of HCI-EC-23 a novel estrogen- and progesterone-responsive endometrial cancer cell line. | Sci Rep | 2022 | 36396974 | PubTator, text mining | PubMed |
| Identification of six hub genes in mantle cell lymphoma patients with BTKi resistance. | Ann Transl Med | 2022 | 36388812 | PubTator, text mining | PubMed |
| Clinical implication of genetic composition and molecular mechanism on treatment strategies of HER2-positive breast cancers. | Front Oncol | 2022 | 36387174 | PubTator, text mining | PubMed |
| Analysis of prognostic oncogene filaggrin (FLG) wild-type subtype and its implications for immune checkpoint blockade therapy in bladder urothelial carcinoma. | Transl Androl Urol | 2022 | 36386263 | PubTator, text mining | PubMed |
| MEDICC2: whole-genome doubling aware copy-number phylogenies for cancer evolution. | Genome Biol | 2022 | 36376909 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58508/papers?page=48